Acute kidney injury: Clinical

To be retired ⓘ

00:00 / 00:00

Notes

Assessments

Acute kidney injury: Clinical

USMLE® Step 2 questions

0 / 4 complete

Questions

USMLE® Step 2 style questions USMLE

of complete

A 38-year-old woman comes to the emergency department for evaluation of altered mental status that began five hours ago. She is accompanied by her husband. Past medical history is notable for asthma and diffuse scleroderma. On arrival, her temperature is 37.6°C (99.7°F) and blood pressure is 183/121 mmHg. On physical examination, the patient is oriented to self but neither time nor place. Diffuse thickening of the skin is observed, and contractures are present in the bilateral fingers. Laboratory testing is obtained, and results are as follows:  
 
 Laboratory value  Result 
 Hemoglobin  10.7 g/dL 
 Leukocyte Count  7,300/mm3 
 Platelet Count  80,000/mm3 
 Blood Urea Nitrogen  35 mg/dL 
 Creatinine, Serum  2.0 mg/dL 
Which of the following is the next best step in the management of this patient’s condition?

Transcript

With acute kidney injury, or AKI, there’s a decrease in kidney function that typically happens over a few days. This leads to the retention of urea and other nitrogenous waste products- such as ammonia and uric acid and dysregulation of extracellular volume and electrolytes.

The most commonly used diagnostic criteria for AKI are the Kidney Disease: Improving Global Outcomes or KDIGO guidelines. The KDIGO guidelines define AKI as an increase in serum creatinine of at least 0.3 milligrams per deciliter within 48 hours or as an increase in serum creatinine by 1.5 times the baseline serum creatinine within the last 7 days or when the urine volume has been less than 0.5 milliliters per kilogram per hour for six hours. Based on these criteria, there are three stages of AKI, where stage 1 is mild and stage 3 is severe AKI. In stage 1 AKI, there’s an increase in serum creatinine to 1.5 to 1.9 times the baseline serum creatinine or an increase in serum creatinine by 0.3 milligrams per deciliter or a decrease in urine output to below 0.5 milliliters per kilogram per hour for 6 to 12 hours. In stage 2 AKI, there’s an increase in serum creatinine to 2 to 2.9 times the baseline serum creatinine or a decrease in urine output to less than 0.5 milliliters per kilogram per hour for more than 12 hours. In stage 3 AKI, there’s an increase in serum creatinine to 3 times the baseline serum creatinine or an increase in serum creatinine to more than 4 milligrams per deciliter or a decrease in urine output to less than 0.3 milliliters per kilogram per hour for more than 24 hours or anuria- meaning less than 100 milliliters per day of urine- for more than 12 hours or where renal replacement therapy has been initiated. All individuals are classified according to whichever criteria places them in the most severe stage of injury.

Once diagnosed, the causes of AKI can be split into prerenal, intrarenal, and post-renal causes. In prerenal AKI, there’s decreased blood flow into the kidneys. This can happen in hypovolemic states like an acute hemorrhage, gastrointestinal losses- like with diarrhea and vomiting, renal losses- like with diuretics or osmotic diuresis in hyperglycemia, dermal losses- like with burns and finally sequestration of fluid- also known as third-spacing- like with acute pancreatitis or sepsis. On the clinical examination, there’s tachycardia, hypotension, reduced skin turgor, and cool extremities.

Summary

Acute kidney injury (AKI) is a sudden, potentially reversible decline in renal function. AKI results in the accumulation of water, nitrogenous wastes, sodium, and other metabolic wastes in the body, and can also lead to electrolyte imbalances. Common causes include dehydration, sepsis, and some drug therapy.

AKI often presents with reduced urine output, but there can be other signs such as edema, and those associated with the accumulation of metabolic wastes such as anorexia, seizures, and altered mental status. Left untreated, it can lead to chronic kidney disease (CKD)

Elsevier

Copyright © 2023 Elsevier, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies.

Cookies are used by this site.

USMLE® is a joint program of the Federation of State Medical Boards (FSMB) and the National Board of Medical Examiners (NBME). COMLEX-USA® is a registered trademark of The National Board of Osteopathic Medical Examiners, Inc. NCLEX-RN® is a registered trademark of the National Council of State Boards of Nursing, Inc. Test names and other trademarks are the property of the respective trademark holders. None of the trademark holders are endorsed by nor affiliated with Osmosis or this website.

RELX